Chidamide, Venetoclax, Azacitidine, and Homoharringtonine for High-risk Fit AML
Clinical trial NCT07643636 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07643636
- Sponsor
- Dongguan People's Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-30
- Primary completion
- 2028-06-01
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.